Nuveen’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.25M | Sell |
363,682
-49,777
| -12% | -$307K | ﹤0.01% | 2235 |
|
|
2025
Q4 | $2.78M | Sell |
413,459
-23,010
| -5% | -$173K | ﹤0.01% | 2158 |
|
|
2025
Q3 | $3.57M | Buy |
436,469
+177,680
| +69% | +$1.33M | ﹤0.01% | 2068 |
|
|
2025
Q2 | $1.82M | Buy |
258,789
+104,946
| +68% | +$706K | ﹤0.01% | 2350 |
|
|
2025
Q1 | $1.1M | Buy |
153,843
+89,500
| +139% | +$844K | ﹤0.01% | 2600 |
|
|
2024
Q4 | $590K | Hold |
64,343
| – | – | ﹤0.01% | 2928 |
|
|
2024
Q3 | $624K | Hold |
64,343
| – | – | ﹤0.01% | 2939 |
|
|
2024
Q2 | $523K | Buy |
64,343
+4,351
| +7% | +$33.7K | ﹤0.01% | 2975 |
|
|
2024
Q1 | $484K | Hold |
59,992
| – | – | ﹤0.01% | 2987 |
|
|
2023
Q4 | $329K | Buy |
59,992
+471
| +0.8% | +$2.49K | ﹤0.01% | 3128 |
|
|
2023
Q3 | $311K | Sell |
59,521
-740
| -1% | -$5.26K | ﹤0.01% | 2956 |
|
|
2023
Q2 | $696K | Sell |
60,261
-93,456
| -61% | -$1.1M | ﹤0.01% | 2819 |
|
|
2023
Q1 | $1.92M | Buy |
153,717
+5,224
| +4% | +$100K | ﹤0.01% | 2349 |
|
|
2022
Q4 | $2.93M | Buy |
148,493
+55,466
| +60% | +$1.19M | ﹤0.01% | 2209 |
|
|
2022
Q3 | $2.26M | Sell |
93,027
-1,528
| -2% | -$42.2K | ﹤0.01% | 2339 |
|
|
2022
Q2 | $2.29M | Buy |
94,555
+7,355
| +8% | +$195K | ﹤0.01% | 2369 |
|
|
2022
Q1 | $2.92M | Buy |
87,200
+1,571
| +2% | +$49.4K | ﹤0.01% | 2336 |
|
|
2021
Q4 | $2.91M | Sell |
85,629
-2,266
| -3% | -$82.3K | ﹤0.01% | 2384 |
|
|
2021
Q3 | $3.79M | Sell |
87,895
-9,541
| -10% | -$587K | ﹤0.01% | 2358 |
|
|
2021
Q2 | $6.35M | Sell |
97,436
-6,315
| -6% | -$400K | ﹤0.01% | 2119 |
|
|
2021
Q1 | $5.45M | Buy |
103,751
+2,919
| +3% | +$146K | ﹤0.01% | 2131 |
|
|
2020
Q4 | $4.51M | Buy |
100,832
+3,138
| +3% | +$108K | ﹤0.01% | 2130 |
|
|
2020
Q3 | $2.83M | Buy |
97,694
+2,973
| +3% | +$93.4K | ﹤0.01% | 2212 |
|
|
2020
Q2 | $3.37M | Buy |
94,721
+19,200
| +25% | +$809K | ﹤0.01% | 2102 |
|
|
2020
Q1 | $3.9M | Buy |
75,521
+5,937
| +9% | +$285K | ﹤0.01% | 1851 |
|
|
2019
Q4 | $4.75M | Sell |
69,584
-1,825
| -3% | -$114K | ﹤0.01% | 2028 |
|
|
2019
Q3 | $3.42M | Sell |
71,409
-1,863
| -3% | -$97.2K | ﹤0.01% | 2149 |
|
|
2019
Q2 | $4.89M | Buy |
+73,272
| New | +$5.58M | ﹤0.01% | 2006 |
|
|
2015
Q4 | – | Sell |
-53,649
| Closed | -$2.6K | – | 1546 |
|
|
2015
Q3 | $2.6K | Sell |
53,649
-14,738
| -22% | -$700K | 0.01% | 661 |
|
|
2015
Q2 | $3.05K | Sell |
68,387
-4,345
| -6% | -$167K | 0.02% | 654 |
|
|
2015
Q1 | $2.33M | Sell |
72,732
-35,294
| -33% | -$1.14M | 0.01% | 785 |
|
|
2014
Q4 | $3.39M | Buy |
+108,026
| New | +$2.62M | 0.02% | 652 |
|
Other funds holding INGN
AC
VCM
DCM
Nuveen's INGN Position: Q1 2026 in Review
Nuveen reduced its Inogen (INGN) stake by 12% in Q1 2026, selling an estimated $307K and leaving 363,682 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2235.
Nuveen first reported a position in INGN in Q4 2014 and has held it in 32 quarters since. The position peaked at $6.35M in Q2 2021. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.
- Nuveen held 363,682 shares of Inogen worth $2.25M as of Q1 2026.
- Nuveen sold 49,777 Inogen shares in Q1 2026, an estimated $307K.
- Inogen made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2235 holding.
- Nuveen first reported a position in Inogen in Q4 2014 and has held it in 32 quarters since.
- Nuveen's Inogen position peaked at $6.35M in Q2 2021.
- 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.